Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin79.7%-0.5pp79.8%-0.6pp79.9%-0.7pp80.1%-0.6pp80.2%-0.7pp
Operating margin-26.9%-2.1pp-25.5%+1.1pp-22.1%+8.6pp-22.4%+10.3pp-24.8%+4.1pp
Net margin-29.4%-4.3pp-27.7%-1.1pp-22.9%+7.4pp-23%+9.1pp-25.1%+2.8pp
Returns
Return on equity-66.9%-21.1pp-58.9%-14.5pp-51.6%-0.9pp-46.9%+1.7pp-45.7%-7.2pp
Return on invested capital-37.1%-7.1pp-33.9%-3.5pp-30.8%+3.4pp-29.6%+5.3pp-30%-0.5pp
Efficiency
Asset turnover1.1×+0.1×+0.2×1.1×+0.2×+0.2×0.9×+0.1×
Liquidity
Current ratio3.6×-0.9×4.3×-0.3×3.4×-0.7×3.5×-0.3×4.5×+0.5×
Leverage
Debt-to-equity0.9×+0.3×0.8×+0.2×0.8×+0.1×0.7×+0.1×0.7×+0.1×
Per Share
Book value per share$1.20-28.9%$1.38-24.1%$1.40-16.7%$1.55-14.2%$1.68-17.8%
Valuation
Market capitalization$258.19M-26.6%$156.11M-66.3%$423.89M+17.7%$372.4M-9.4%$525.37M-34.8%
Price / sales1.3×-0.4×0.7×-1.5×1.9×+0.2×1.7×-0.3×2.5×-1.6×
Price / book3.3×-0.3×1.8×-2.3×4.8×+1.3×3.8×+0.2×-1.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Treace Medical Concepts, Inc.'s profit margins?
Treace Medical Concepts, Inc. (TMCI) runs a 79.7% gross margin and a -26.9% operating margin, with a -29.4% net margin.
Where do Treace Medical Concepts, Inc.'s ratios come from?
Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.